The latest closing stock price for BioXcel Therapeutics as of March 28, 2025 is 2.12.
An investor who bought $1,000 worth of BioXcel Therapeutics stock at the IPO in 2018 would have $-808 today, roughly -1 times their original investment - a -20.99% compound annual growth rate over 7 years.
The all-time high BioXcel Therapeutics stock closing price was 64.63 on July 22, 2020.
The BioXcel Therapeutics 52-week high stock price is 6.83, which is 222.2% above the current share price.
The BioXcel Therapeutics 52-week low stock price is 0.16, which is 92.5% below the current share price.
The average BioXcel Therapeutics stock price for the last 52 weeks is 1.24.
An investor who bought $1,000 worth of BioXcel Therapeutics stock at the IPO in 2018 would have $-808 today, roughly -1 times their original investment - a -20.99% compound annual growth rate over 7 years.
The all-time high BioXcel Therapeutics stock closing price was 64.63 on July 22, 2020.
The BioXcel Therapeutics 52-week high stock price is 6.83, which is 222.2% above the current share price.
The BioXcel Therapeutics 52-week low stock price is 0.16, which is 92.5% below the current share price.
The average BioXcel Therapeutics stock price for the last 52 weeks is 1.24.